Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brain-Gut Research Group is a specialized clinical research organization and dedicated study site based in Kansas City, Missouri, focusing on gastroenterology and neurogastroenterology. The group conducts Phase II through IV clinical trials for global pharmaceutical and biotechnology sponsors, with a particular emphasis on disorders of the brain-gut axis such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). They provide comprehensive site services, including patient recruitment, clinical trial management, and high-quality data acquisition. By focusing on gastrointestinal motility and functional disorders, the organization plays a critical role in the clinical development of new GI therapies. The group is led by experienced investigators and is recognized for its contributions to clinical research in the Midwest.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brain-Gut Research Group.